Estimating lead time and sensitivity in a screening program without estimating the incidence in the screened group

Biometrics

Volumn 53, Issue 1, 1997, Pages 217-229

  Straatman, Huub ^a   Peer, Petronella G M ^a   Verbeek, André L M ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

Author keywords

Breast cancer screening; Lead time; Sensitivity

Indexed keywords

DIAGNOSIS; MAXIMUM LIKELIHOOD ESTIMATION; SOFTWARE TESTING;

BREAST CANCER; BREAST CANCER SCREENING; CHRONIC DISEASE; EARLY INDICATORS; LEADTIME; SCREENING EXAMINATIONS; SCREENING PROGRAMS; SCREENING TESTS; SENSITIVITY; TIME INTERVAL;

DISEASES;

ADULT; ARTICLE; BREAST CANCER; CANCER SCREENING; DIAGNOSTIC ACCURACY; HUMAN; MAJOR CLINICAL STUDY; PREDICTION; SCREENING TEST; STATISTICAL MODEL;

EID: 0030933667     PISSN: 0006341X     EISSN: None     Source Type: Journal    
DOI: 10.2307/2533109     Document Type: Article

References (34)

1. Albert, A., Gertman, P. M., and Louis, T. A. (1978a). Screening for the early detection of cancer: I. The temporal natural history of a progressive disease state. Mathematical Biosciences 40, 1-59.
2. Albert, A., Gertman, P. M., Louis, T. A., and Liu, S. (1978b). Screening for the early detection of cancer: II. The impact of screening on the natural history of the disease. Mathematical Biosciences 40, 61-109.
3. Alexander, F. E. (1989). Estimation of sojourn time distributions and false negative rates in screening programmes which use two modalities. Statistics in Medicine 8, 743-755.
4. Baker, S. G. and Chu K. C. (1990). Evaluating screening for the early detection and treatment of cancer without using a randomized control group. Journal of the American Statistical Association 85, 321-327.
5. Brookmeyer, R. and Day, N. E. (1987). Two-stage models for the analysis of cancer screening data. Biometrics 43, 657-669.
6. Brookmeyer, R., Day, N. E., and Moss, S. (1986). Case-control studies for estimation of the natural history of preclinical disease from screening data. Statistics in Medicine 5, 127-138.
7. Cox, D. R. (1975). Partial likelihood. Biometrika 62, 269-276.
8. Day, N. E. (1985). Estimating the sensitivity of a screening test. Journal of Epidemiology and Community Health 39, 364-366.
9. Day, N. E. and Walter, S. D. (1984). Simplified models of screening for chronic disease: Estimation procedures from mass screening programmes. Biometrics 40, 1-14.
10. de Koning, H. J., van Ineveld, B. M., van Oortmarssen, G. J., de Haes, J. C. J. M., Collette, H. J. A. Hendriks, J. H. C. L., and van der Mass, P. J. (1991). Breast cancer screening and cost-effectiveness; policy alternatives, quality of life considerations and the possible impact of certain factors. International Journal of Cancer 49, 531-537.
11. Dubin, N. (1979). Benefits of screening for breast cancer: Application of a probabilistic model to a breast cancer detection project. Journal of Chronic Disease 32, 145-151.
12. Eddy, D. (1980). Screening for Cancer: Theory, Analysis and Design. Englewood Cliffs, New Jersey: Prentice-Hall.
13. Flehinger, B. J. and Kimmel, M. K. (1987). The natural history of lung cancer in a periodically screened population. Biometrics 43, 127-144.
14. Fox, H., Moskowitz, M., Saenger, L., Kereiakes, J. G., Milbrath, J., and Goodman, M. W. (1978). Benefit/risk analyses of aggressive mammographic screening. Radiology 128, 359-365.
15. Goldberg, J. D. and Wittes, J. T. (1978). The estimation of false negatives in medical screening. Biometrics 34, 77-86.
16. Hutchison, G. B. and Shapiro, S. (1968). Lead time gained by diagnostic screening for breast cancer. Journal of the National Cancer Institute 41, 665-681.
17. Morrison, A. S. (1985). Screening in Chronic Disease. Monographs in Epidemiology and Biostatistics, Volume 7. New York: Oxford University Press.
18. Paci, E. and Duffi, S. W. (1991). Modelling the analyses of breast cancer screening programmes: Sensitivity, lead time, and predictive value in the Florence district programme (1975-1986). International Journal of Epidemiology 20(4), 852-858.
19. Peeters, P. H. M., Verbeek, A. L. M., Hendriks, J. H. C. L., and van Bon, M. J. H. (1989a). Screening for breast cancer in Nijmegen; report of 6 screening rounds, 1975-1986. International Journal of Cancer 43, 226-230.
20. Peeters, P. H. M., Verbeek, A. L. M., Straatman, H., Holland. R., Hendriks, J. H. C. L., Mravunac, M., van Dijk-Milatz, A., and Werre, J. M. (1989b). Evaluation of overdiagnosis of breast cancer in screening with mammography: Results of the Nijmegen programme. International Journal of Epidemiology 18, 295-299.
21. Prorok, P. C. (1976a). The theory of periodic screening. I: Lead time and proportion detected. Advances in Applied Probability 8, 127-143.
22. Prorok, P. C. (1976b). The theory of periodic screening. II: Doubly bounded recurrence times and mean lead time and detection probability estimation. Advances in Applied Probability 8, 460-476.
23. Seidman, H. (1977). Screening for breast cancer in younger women: Life expectancy gains and losses. CA: A Cancer Journal for Clinicians 27, 66-87.
24. Shapiro, S. (1977). Evidence of screening for breast cancer from a randomized trial. Cancer 39, 2772-2782.
25. Shapiro, S., Goldberg, J. D., and Hutchison, G. B. (1974). Lead time in breast cancer detection and implications for periodicity of screening. American Journal of Epidemiology 100, 357-366.
26. Shwartz, M. (1978). An analysis of the benefits of serial screening for breast cancer based upon a mathematical model of the disease. Cancer 41, 1550-1564.
27. Tallis, G. M. and Sarfati, G. (1974). On the distribution of the time to reporting cancers with application to breast cancer in women. Mathematical Biosciences 128, 371-376.
28. van Oortmarssen, G. J., Habbema, J. D. F., van der Maas, P. J., de Koning, H. J., Collette, H. J. A., Verbeek, A. L. M., Geerts, A. T., and Lubbe, T. N. (1990a). A model for breast cancer screening. Cancer 66, 1601-1612.
29. van Oortmarssen, G. J., Habbema, J. D. F., Lubbe, T. N., and van der Maas, P. J. (1990b). A model-based analysis of the HIP project for breast cancer screening. International Journal of Cancer 46, 207-213.
30. Verbeek, A. L. M., Hendriks, J. H. C. L., Holland, R., Mravunac, M., Day, N. E., and Sturmans, F. (1984). Reduction of breast cancer mortality through mass screening with modern mammography: First results of the Nijmegen project, 1975-1981. Lancet i, 1222-1224.
31. Walter, S. D. and Day, N. E. (1983). Estimation of the duration of a pre-clinical disease state using screening data. American Journal of Epidemiology 118, 865-886.
32. Walter, S. D. and Stitt, L. W. (1987). Evaluating the survival of cancer cases detected by screening. Statistics in Medicine 6, 885-900.
33. Zelen, M. (1993). Optimal scheduling of examinations for the early detection of disease. Biometrika 80, 279-293.
34. Zelen, M. and Feinleib, M. (1969). On the theory of screening for chronic diseases. Biometrika 56, 601-614.